Changes in bone biomarkers in antiretroviral naïve HIV-infected men randomised to nevirapine/lopinavir/ritonavir (NVP/LPV/R) or zidovudine/lamivudine/lopinavir/ritonavir (AZT/3TC/LPV/R) help explain limited loss of bone mineral density over first 12 months
Murray, B.F, van Vonderen, M.G, Mallon, P.W, Doran, P, van Agtmael, M.A, Danner, S.A, Lips, P, Reiss, P
Published in Bone (New York, N.Y.) (01.05.2012)
Published in Bone (New York, N.Y.) (01.05.2012)
Get full text
Journal Article
Changes in bone biomarkers in antiretroviral naïve HIV-infected men randomised to nevirapine/lopinavir/ritonavir (NVP/LPV/R) or zidovudine/lamivudine/lopinavir/ritonavir (AZT/3TC/LPV/R) help explain limited loss of bone mineral density over first 12months
Murray⁎, B.F., van Vonderen, M.G., Mallon, P.W., Doran, P., van Agtmael, M.A., Danner, S.A., Lips, P., Reiss, P.
Published in Bone (New York, N.Y.) (01.05.2012)
Published in Bone (New York, N.Y.) (01.05.2012)
Get full text
Journal Article